SaNOtize, Israel-based makers of a Covid nasal spray, have just received a $10 million investment. Its antiviral nasal spray is now sold in 10 countries, registered as a Class I medical device in the EU, and has ongoing approval procedures elsewhere. In July, a report in The Lancet, the world’s most respected medical journal, concluded […]

Clinical trials of a nasal spray developed by Israeli-founded. SaNOtize show it significantly reduces viral load and shortens the course of COVID-19 A report in The Lancet, the world’s most respected medical journal, concludes that its nitric oxide nasal spray (NONS) used  six times daily for seven days was “efficacious in accelerating the reduction of SARS-CoV-2 RNA from the nasal cavity”. The spray […]

While other global approvals were were focused on prevention, this is the first approval for SaNOtize nasal spray as early treatment for COVID-19.

Glenmark Pharmaceuticals will manufacture the spray in India and intends to produce, market and distribute it to other Asian countries.

SaNOtize is increasing production in Israel and beyond as it attempts to keep up with international demand for its Enovid nasal spray.

SaNOtize signed a deal with India's Glenmark Pharmaceuticals to market and sell their Nitric Oxide Nasal Spray (NONS) in India, Vietnam, and more.

Enovid, SaNOtize’s Nitric Oxide Nasal Spray (NONS), will be sold in Israel after receiving emergency use authorization as a medical device by the Ministry of Health.

The Health Ministry gave interim approval to sell the spray to people aged 12 and over; UK clinical trial shows promising results.

The Nitric Oxide Nasal Spray developed by SaNOtize is designed to kill the virus in the upper airways, preventing it from reaching the lungs.

The Vancouver-based company, co-founded by an Israeli scientist, developed a patented platform for the topical delivery of nitric oxide to treat a variety of bacterial, fungal, and viral diseases.

As of February 19, over 75,000 people worldwide have been infected, nearly all of them in mainland China, and some 2,012 people have died from the coronavirus.